Cyclin-dependent kinase inhibitors--a novel class of prognostic indicators.
- 1 August 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (8) , 769-70
- https://doi.org/10.1053/hupa.2001.27822
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- p27 destruction: Cks1 pulls the triggerNature Cell Biology, 2001
- Multiple functions of p27Kip1 and its alterations in tumor cells: a reviewJournal of Cellular Physiology, 2000
- Regulation of the Cdk inhibitor p27 and its deregulation in cancerJournal of Cellular Physiology, 2000
- Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinomaCancer, 1997
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Inhibition of cyclin-dependent kinases by p21.Molecular Biology of the Cell, 1995
- p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating CellsScience, 1995
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Published by Elsevier ,1994
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993